⌘K

Login Start Free

Home/Filings/4/0000897069-06-002277

4//SEC Filing

DAVIS JEFFREY B 4

Accession 0000897069-06-002277

CIK 0000888671other

View on SEC.gov Company Profile

Filed

Oct 29, 7:00 PM ET

Accepted

Oct 30, 4:10 PM ET

Size

7.6 KB

Accession

0000897069-06-002277

Insider Transaction Report

Form 4

Period: 2006-09-06

Somanta Pharmaceuticals Inc.N/A

DAVIS JEFFREY B

Director

Transactions

Award
Option Grant to purchase Common Stock
2006-09-06+20,000→ 20,000 total
Exercise: $0.60Exp: 2016-09-06→ Common Stock (20,000 underlying)
Award
Option Grant to purchase Common Stock
2006-09-06+5,000→ 5,000 total
Exercise: $0.60Exp: 2016-09-06→ Common Stock (5,000 underlying)

Footnotes (1)

[F1]Each option vests in equal quarterly installments for a period of twenty-four months.

Documents

1 file

4
cmw2383_ex.xmlPrimary

Issuer

Somanta Pharmaceuticals Inc.

CIK 0000888671

Entity typeother

Related Parties

1

filerCIK 0001344651

Filing Metadata

Form type: 4
Filed: Oct 29, 7:00 PM ET
Accepted: Oct 30, 4:10 PM ET
Size: 7.6 KB

View on SEC.gov